Literature DB >> 23184607

Functionalized magnetonanoparticles in visualization of intracranial tumors on MRI.

Massoud Akhtari1, Whitney Pope, Gary Mathern, Rex Moats, Andrew Frew, Mark Mandelkern.   

Abstract

PURPOSE: The development of nonradioactive and targeted magnetonanoparticles (MNP) capable of crossing the blood-brain barrier (BBB) and of concentrating in and enhancing the contrast of intracranial tumors on magnetic resonance imaging (MRI). PROCEDURE: Nonradioactive 2-deoxy-D-glucose (2DG) was covalently attached to magnetonanoparticles composed of iron oxide and dextran and prepared for intravenous (tail) injection in the naïve rats and mouse models of glioma. MR images were acquired at 3 and 7 T.
RESULTS: 2DG-MNP increased tumor visibility and improved delineation of tumor margins. Histopathology confirmed that 2DG-MNP crossed the BBB and accumulated within brain parenchyma.
CONCLUSION: Nonradioactive 2DG-MNP can cross an intact BBB on and improve visualization of tumor and tumor margins on MRI.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23184607     DOI: 10.1007/s11307-012-0601-z

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN: 1536-1632            Impact factor:   3.488


  14 in total

Review 1.  Recent advances in iron oxide nanocrystal technology for medical imaging.

Authors:  Claire Corot; Philippe Robert; Jean-Marc Idée; Marc Port
Journal:  Adv Drug Deliv Rev       Date:  2006-09-30       Impact factor: 15.470

2.  Imaging brain neuronal activity using functionalized magnetonanoparticles and MRI.

Authors:  Massoud Akhtari; Anatol Bragin; Rex Moats; Andrew Frew; Mark Mandelkern
Journal:  Brain Topogr       Date:  2012-05-24       Impact factor: 3.020

Review 3.  Response assessment challenges in clinical trials of gliomas.

Authors:  Patrick Y Wen; Andrew D Norden; Jan Drappatz; Eudocia Quant
Journal:  Curr Oncol Rep       Date:  2010-01       Impact factor: 5.075

4.  AuNP-DG: deoxyglucose-labeled gold nanoparticles as X-ray computed tomography contrast agents for cancer imaging.

Authors:  Bulent Aydogan; Ji Li; Tijana Rajh; Ahmed Chaudhary; Steven J Chmura; Charles Pelizzari; Christian Wietholt; Metin Kurtoglu; Peter Redmond
Journal:  Mol Imaging Biol       Date:  2010-10       Impact factor: 3.488

5.  Combination of single-voxel proton MR spectroscopy and apparent diffusion coefficient calculation in the evaluation of common brain tumors.

Authors:  Nail Bulakbasi; Murat Kocaoglu; Fatih Ors; Cem Tayfun; Taner Uçöz
Journal:  AJNR Am J Neuroradiol       Date:  2003-02       Impact factor: 3.825

Review 6.  Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas.

Authors:  M J van den Bent; J S Wefel; D Schiff; M J B Taphoorn; K Jaeckle; L Junck; T Armstrong; A Choucair; A D Waldman; T Gorlia; M Chamberlain; B G Baumert; M A Vogelbaum; D R Macdonald; D A Reardon; P Y Wen; S M Chang; A H Jacobs
Journal:  Lancet Oncol       Date:  2011-04-05       Impact factor: 41.316

7.  Imaging, distribution, and toxicity of superparamagnetic iron oxide magnetic resonance nanoparticles in the rat brain and intracerebral tumor.

Authors:  Leslie L Muldoon; Manninger Sàndor; Kristina E Pinkston; Edward A Neuwelt
Journal:  Neurosurgery       Date:  2005-10       Impact factor: 4.654

8.  Evaluation of neck and body metastases to nodes with ferumoxtran 10-enhanced MR imaging: phase III safety and efficacy study.

Authors:  Yoshimi Anzai; Catherine W Piccoli; Eric K Outwater; William Stanford; David A Bluemke; Pamela Nurenberg; Sanjay Saini; Kenneth R Maravilla; David E Feldman; Udo P Schmiedl; James A Brunberg; Isaac R Francis; Steven E Harms; Peter M Som; Clare M Tempany
Journal:  Radiology       Date:  2003-09       Impact factor: 11.105

Review 9.  Overview of nanoparticle use in cancer imaging.

Authors:  Tina Islam; Mukesh G Harisinghani
Journal:  Cancer Biomark       Date:  2009       Impact factor: 4.388

10.  Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice.

Authors:  John F de Groot; Gregory Fuller; Ashok J Kumar; Yuji Piao; Karina Eterovic; Yongjie Ji; Charles A Conrad
Journal:  Neuro Oncol       Date:  2010-01-06       Impact factor: 12.300

View more
  1 in total

Review 1.  Targeting Glioblastoma with the Use of Phytocompounds and Nanoparticles.

Authors:  Francesca Pistollato; Susanne Bremer-Hoffmann; Giuseppe Basso; Sandra Sumalla Cano; Iñaki Elio; Manuel Masias Vergara; Francesca Giampieri; Maurizio Battino
Journal:  Target Oncol       Date:  2016-02       Impact factor: 4.493

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.